Effectivity and Safety of Metronidazole 1% Cream in Rosacea Therapy
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Rosacea is a chronic inflammatory disease of the central facial region, which can also occur
in the neck and chest regions. Microbes that play a role in rosacea are Demodex folliculorum
and Helicobactor pylori. On the skin with rosacea have decreased skin barrier function. This
clinical study will compare the effectiveness and safety of metronidazole 1% cream as the
main therapy in rosacea patients. Participants who will become research subjects are women
and men aged 18-60 years who meet the inclusion criteria. Research subjects were divided into
2 groups. The control group will use placebo cream (without the drug substance) and the
comparison group will use metronidazole 1% cream.
Phase:
Phase 1
Details
Lead Sponsor:
Dr.dr.Irma Bernadette, SpKK (K)
Collaborator:
Science and Technology Park, Center of Innovation Technologies for Human Health